Lee's Pharmaceutical Holdings Ltd Sustainability Reports
An integrated research-driven and market-oriented biopharmaceutical company. It is engaged in the drug development, clinical development, manufacturing, sales, and marketing of proprietary and licensed-in pharmaceutical products.
Sector: Manufacturing
Country: Hong Kong
Exchange: Hong Kong Stock Exchange
LEI: 21380057SDS1LER3KZ63
FIGI: BBG001SCV513
24 reports from 2011 to 2025
- Lee's Pharmaceutical Holdings Ltd 2025 Annual Report
- Lee's Pharmaceutical Holdings Ltd 2025 Environmental, Social and Governance Report
- Lee's Pharmaceutical Holdings Ltd 2024 Annual Report
- Lee's Pharmaceutical Holdings Ltd 2024 Environmental, Social and Governance Report
- Lee's Pharmaceutical Holdings Ltd 2023 Annual Report